BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201001T121500
DTEND;TZID=America/New_York:20201001T131500
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:KRAS\; A Key Oncogenic Driver and Novel Investigational Target in NSCLC
DESCRIPTION:Join us for a session on KRAS. The program will feature expert speakers reviewing the evolving NSCLC landscape and emerging biomarkers\, raise awareness that KRAS G12C is the most prevalent emerging molecular target in NSCLC\, define patient and tumor characteristics\, and discuss clinical guideline recommendations for molecular testing at diagnosis of NSCLC.FLASCO Members Participate for FREE!
X-ALT-DESC;FMTTYPE=text/html:Join us for a session on KRAS. The program will feature expert speakers reviewing the evolving NSCLC landscape and emerging biomarkers\, raise awareness that KRAS G12C is the most prevalent emerging molecular target in NSCLC\, define patient and tumor characteristics\, and discuss clinical guideline recommendations for molecular testing at diagnosis of NSCLC.FLASCO Members Participate for FREE!
LOCATION:
UID:e.603.227611
SEQUENCE:3
DTSTAMP:20260514T131457Z
URL:https://members.flasco.org/calendarofevents/Details/kras-a-key-oncogenic-driver-and-novel-investigational-target-in-nsclc-248349?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR